Sign in

CIK 0000872589 · Large accelerated filer

REGENERON PHARMACEUTICALS, INC.

Sign in to watch
Ticker
REGN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NY
Entity type
operating
EIN
133444607
Phone
9148477000
Business address
777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY, 10591
Former names
REGENERON PHARMACEUTICALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$51,901,544
in 11 filings, $8.6M under 10b5-1 plans

Net −$51,901,544. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-03-27 Landry Robert E EVP Finance CFO Sale 10b5-1 −4 $829.16 $3K 32,936
2023-03-27 Landry Robert E EVP Finance CFO Sale 10b5-1 −7 $830.01 $6K 32,929
2023-03-27 Landry Robert E EVP Finance CFO Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 −3,000 20,337
2023-03-27 Landry Robert E EVP Finance CFO Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 −800 0
2023-03-24 Bassler Bonnie L Director Option exercise 10b5-1 +1,240 $380.95 $472K 2,487
2023-03-24 Bassler Bonnie L Director Sale 10b5-1 −1,240 $818.00 $1.0M 1,247
2023-03-24 Bassler Bonnie L Director Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 −1,240 2,480
2023-03-23 VAGELOS P ROY Director Gift 10b5-1 −25,000 312,578
2023-03-23 YANCOPOULOS GEORGE President and Chief Scientific Sale 10b5-1 −254 $800.59 $203K 200,250
2023-03-23 YANCOPOULOS GEORGE President and Chief Scientific Sale 10b5-1 −122 $801.16 $98K 200,128
2023-03-23 YANCOPOULOS GEORGE President and Chief Scientific Sale 10b5-1 −1,237 $802.54 $993K 198,891
2023-03-23 YANCOPOULOS GEORGE President and Chief Scientific Sale 10b5-1 −642 $803.30 $516K 198,249
2023-03-23 YANCOPOULOS GEORGE President and Chief Scientific Sale 10b5-1 −254 $804.38 $204K 197,995
2023-03-23 YANCOPOULOS GEORGE President and Chief Scientific Sale 10b5-1 −47 $805.55 $38K 197,948
2023-03-23 YANCOPOULOS GEORGE President and Chief Scientific Sale 10b5-1 −700 $806.47 $565K 197,248
2023-03-23 YANCOPOULOS GEORGE President and Chief Scientific Sale 10b5-1 −400 $810.30 $324K 196,848
2023-03-23 LAROSA JOSEPH J EVP General Counsel and Secret Option exercise +10,000 $270.43 $2.7M 34,213
2023-03-23 LAROSA JOSEPH J EVP General Counsel and Secret Shares withheld for taxes −6,742 $801.59 $5.4M 27,471
2023-03-23 LAROSA JOSEPH J EVP General Counsel and Secret Option exercise · Non-Qualified Stock Option (right to buy) −10,000 0
2023-03-23 Fenimore Christopher R. SVP Controller Sale 10b5-1 −2,192 $806.47 $1.8M 18,409

Page 55 of 105 · 2,088 trades